Th1 cytokine responses fail to effectively control Chlamydia lung infection in ICOS ligand knockout mice

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3780-3788

  Kadkhoda, Kamran ^a   Wang, Shuhe ^a   Joyee, Antony George ^a   Fan, Yijun ^a   Yang, Jie ^a   Yang, Xi ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; ICOS LIGAND; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; ICOSL PROTEIN, MOUSE; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; PROTEIN; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CELL CONTACT; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOREGULATION; KNOCKOUT MOUSE; LUNG FIBROBLAST; LUNG INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL SEPARATION; CHLAMYDIA INFECTIONS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEINS; RESPIRATORY TRACT INFECTIONS; TH1 CELLS;

EID: 77951628752     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901384     Document Type: Article

References (48)

1. Swallow, M. M., J. J. Wallin, and W. C. Sha. 1999. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11: 423-432.
2. Yoshinaga, S. K., J. S. Whoriskey, S. D. Khare, U. Sarmiento, J. Guo, T. Horan, G. Shih, M. Zhang, M. A. Coccia, T. Kohno, et al. 1999. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832. (Pubitemid 129638129)
3. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
4. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
5. Chapoval, A. I., J. Ni, J. S. Lau, R. A. Wilcox, D. B. Flies, D. Liu, H. Dong, G. L. Sica, G. Zhu, K. Tamada, and L. Chen. 2001. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2: 269-274.
6. Latchman, Y., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
7. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20: 29-53.
8. Hutloff, A., K. Büchner, K. Reiter, H. J. Baelde, M. Odendahl, A. Jacobi, T. Dörner, and R. A. Kroczek. 2004. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50: 3211-3220. (Pubitemid 39371998)
9. Yoshinaga, S. K., M. Zhang, J. Pistillo, T. Horan, S. D. Khare, K. Miner, M. Sonnenberg, T. Boone, D. Brankow, T. Dai, et al. 2000. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 12: 1439-1447.
10. Aicher, A., M. Hayden-Ledbetter, W. A. Brady, A. Pezzutto, G. Richter, D. Magaletti, S. Buckwalter, J. A. Ledbetter, and E. A. Clark. 2000. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164: 4689-4696. (Pubitemid 30238069)
11. Qian, X., K. Agematsu, G. J. Freeman, Y. Tagawa, K. Sugane, and T. Hayashi. 2006. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system. Eur. J. Immunol. 36: 906-918.
12. Farina, C., D. Theil, B. Semlinger, R. Hohlfeld, and E. Meinl. 2004. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int. Immunol. 16: 799-809.
13. Ling, V., P. W. Wu, J. S. Miyashiro, S. Marusic, H. F. Finnerty, and M. Collins. 2001. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules. J. Immunol. 166: 7300-7308. (Pubitemid 32525605)
14. Taylor, P. A., A. Panoskaltsis-Mortari, G. J. Freeman, A. H. Sharpe, R. J. Noelle, A. Y. Rudensky, T. W. Mak, J. S. Serody, and B. R. Blazar. 2005. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood 105: 3372-3380.
15. Khayyamian, S., A. Hutloff, K. Büchner, M. Gräfe, V. Henn, R. A. Kroczek, and H. W. Mages. 2002. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc. Natl. Acad. Sci. USA 99: 6198-6203.
16. Coyle, A. J., S. Lehar, C. Lloyd, J. Tian, T. Delaney, S. Manning, T. Nguyen, T. Burwell, H. Schneider, J. A. Gonzalo, et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13: 95-105.
17. Reiter, R., and K. Pfeffer. 2002. Impaired germinal centre formation and humoral immune response in the absence of CD28 and interleukin-4. Immunology 106: 222-228. (Pubitemid 34621830)
18. Watanabe, M., S. Watanabe, Y. Hara, Y. Harada, M. Kubo, K. Tanabe, H. Toma, and R. Abe. 2005. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling. J. Immunol. 174: 1989-1996. (Pubitemid 40223940)
19. Riley, J. L., P. J. Blair, J. T. Musser, R. Abe, K. Tezuka, T. Tsuji, and C. H. June. 2001. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J. Immunol. 166: 4943-4948.
20. Löhning, M., A. Hutloff, T. Kallinich, H. W. Mages, K. Bonhagen, A. Radbruch, E. Hamelmann, and R. A. Kroczek. 2003. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197: 181-193.
21. Kroczek, R., and E. Hamelmann. 2005. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J. Allergy Clin. Immunol. 116: 906-909.
22. Schachter, J. 1978. Chlamydial infections (third of three parts). N. Engl. J. Med. 298: 540-549.
23. Ward, M. E. 1995. The immunobiology and immunopathology of chlamydial infections. APMIS 103: 769-796.
24. Sweet, R. L. 1987. Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women. Infect. Dis. Clin. North Am. 1: 199-215.
25. Brunham, R. C., and J. Rey-Ladino. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5: 149-161.
26. Morrison, R. P., and H. D. Caldwell. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70: 2741-2751.
27. Yang, X. 2003. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9: 67-73.
28. Loomis, W. P., and M. N. Starnbach. 2002. T cell responses to Chlamydia trachomatis. Curr. Opin. Microbiol. 5: 87-91.
29. Morrison, S. G., and R. P. Morrison. 2005. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175: 7536-7542.
30. Morrison, S. G., and R. P. Morrison. 2005. The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A. Infect. Immun. 73: 6183-6186.
31. Darville, T., C. W. Andrews, Jr., J. D. Sikes, P. L. Fraley, and R. G. Rank. 2001. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect. Immun. 69: 3556-3561.
32. Qiu, H., J. Yang, H. Bai, Y. Fan, S. Wang, X. Han, L. Chen, and X. Yang. 2004. Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection. Immunology 111: 453-461. (Pubitemid 38482498)
33. Qiu, H., Y. Fan, A. G. Joyee, S. Wang, X. Han, H. Bai, L. Jiao, N. Van Rooijen, and X. Yang. 2008. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181: 2092-2102.
34. Han, X., S. Wang, Y. Fan, J. Yang, L. Jiao, H. Qiu, and X. Yang. 2006. Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice. J. Immunol. 176: 5232-5239.
35. Mak, T. W., A. Shahinian, S. K. Yoshinaga, A. Wakeham, L. M. Boucher, M. Pintilie, G. Duncan, B. U. Gajewska, M. Gronski, U. Eriksson, et al. 2003. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4: 765-772.
36. Joyee, A. G., H. Qiu, S. Wang, Y. Fan, L. Bilenki, and X. Yang. 2007. Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J. Immunol. 178: 1048-1058.
37. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
38. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
39. Igietseme, J. U., P. B. Wyrick, D. Goyeau, and R. G. Rank. 1994. An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect. Immun. 62: 3528-3535.
40. Kobayashi, Y. 2008. The role of chemokines in neutrophil biology. Front. Biosci. 13: 2400-2407.
41. Williams, L. M., F. Lali, K. Willetts, C. Balague, N. Godessart, F. Brennan, M. Feldmann, and B. M. Foxwell. 2008. Rac mediates TNF-induced cytokine production via modulation of NF-kappaB. Mol. Immunol. 45: 2446-2454.
42. Wittmann, S., G. Rothe, G. Schmitz, and D. Fröhlich. 2004. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response. Cytometry A 57: 53-62. (Pubitemid 38055715)
43. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101. (Pubitemid 32098632)
44. Bai, H., J. Cheng, X. Gao, A. G. Joyee, Y. Fan, S. Wang, L. Jiao, Z. Yao, and X. Yang. 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183: 5886-5895.
45. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, and J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340.
46. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
47. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
48. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.